TCL Archive In Brief: Cancer Research Institute to Support AIDS Grants, With Maximum $70,000 Each; Deadline Is Oct. 1 July 15, 1983
TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance December 13, 1996
TCL Archive DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan June 10, 1988
